Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
Saved in:
| Title: | Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies. |
|---|---|
| Authors: | Wirchnianski AS; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America., Nyakatura EK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America., Herbert AS; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America., Kuehne AI; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Abbasi SA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America., Florez C; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America., Storm N; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America., McKay LGA; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America., Dailey L; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America., Kuang E; Mapp Biopharmaceutical Inc., San Diego, California, United States of America., Abelson DM; Mapp Biopharmaceutical Inc., San Diego, California, United States of America., Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America., Chakraborti S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America., Holtsberg FW; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America., Shulenin S; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America., Bornholdt ZA; Mapp Biopharmaceutical Inc., San Diego, California, United States of America., Aman MJ; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America., Honko AN; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America., Griffiths A; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America., Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America., Lai JR; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2024 Apr 11; Vol. 20 (4), pp. e1012134. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38603762 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wirchnianski+AS%22">Wirchnianski AS</searchLink>; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Nyakatura+EK%22">Nyakatura EK</searchLink>; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Herbert+AS%22">Herbert AS</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Kuehne+AI%22">Kuehne AI</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Abbasi+SA%22">Abbasi SA</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Florez+C%22">Florez C</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Storm+N%22">Storm N</searchLink>; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22McKay+LGA%22">McKay LGA</searchLink>; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Dailey+L%22">Dailey L</searchLink>; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Kuang+E%22">Kuang E</searchLink>; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Abelson+DM%22">Abelson DM</searchLink>; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Wec+AZ%22">Wec AZ</searchLink>; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Chakraborti+S%22">Chakraborti S</searchLink>; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Holtsberg+FW%22">Holtsberg FW</searchLink>; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Shulenin+S%22">Shulenin S</searchLink>; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Bornholdt+ZA%22">Bornholdt ZA</searchLink>; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Aman+MJ%22">Aman MJ</searchLink>; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Honko+AN%22">Honko AN</searchLink>; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Griffiths+A%22">Griffiths A</searchLink>; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Dye+JM%22">Dye JM</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Chandran+K%22">Chandran K</searchLink>; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Lai+JR%22">Lai JR</searchLink>; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2024 Apr 11; Vol. 20 (4), pp. e1012134. <i>Date of Electronic Publication: </i>2024 Apr 11 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38603762 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1012134 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1012134 Titles: – TitleFull: Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wirchnianski AS – PersonEntity: Name: NameFull: Nyakatura EK – PersonEntity: Name: NameFull: Herbert AS – PersonEntity: Name: NameFull: Kuehne AI – PersonEntity: Name: NameFull: Abbasi SA – PersonEntity: Name: NameFull: Florez C – PersonEntity: Name: NameFull: Storm N – PersonEntity: Name: NameFull: McKay LGA – PersonEntity: Name: NameFull: Dailey L – PersonEntity: Name: NameFull: Kuang E – PersonEntity: Name: NameFull: Abelson DM – PersonEntity: Name: NameFull: Wec AZ – PersonEntity: Name: NameFull: Chakraborti S – PersonEntity: Name: NameFull: Holtsberg FW – PersonEntity: Name: NameFull: Shulenin S – PersonEntity: Name: NameFull: Bornholdt ZA – PersonEntity: Name: NameFull: Aman MJ – PersonEntity: Name: NameFull: Honko AN – PersonEntity: Name: NameFull: Griffiths A – PersonEntity: Name: NameFull: Dye JM – PersonEntity: Name: NameFull: Chandran K – PersonEntity: Name: NameFull: Lai JR IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Text: 2024 Apr 11 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 20 – Type: issue Value: 4 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |